Drug
Ceftaroline Fosamil
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Agranulocytosis | 39 | 54.9 | 57.6 | signal |
| 2 | Toxic Epidermal Necrolysis | 25 | 43.1 | 44.4 | signal |
| 3 | Drug Reaction With Eosinophilia And Systemic Symptoms | 31 | 31.5 | 32.7 | signal |
| 4 | Eosinophilia | 19 | 28.2 | 28.9 | signal |
| 5 | Bacteraemia | 8 | 17.6 | 17.8 | signal |
| 6 | Staphylococcal Infection | 22 | 17.3 | 17.7 | signal |
| 7 | Transaminases Increased | 14 | 16.4 | 16.6 | signal |
| 8 | Cytomegalovirus Infection | 10 | 15.6 | 15.8 | signal |
| 9 | Inappropriate Antidiuretic Hormone Secretion | 6 | 15.3 | 15.4 | signal |
| 10 | Stevens-johnson Syndrome | 13 | 15.1 | 15.4 | signal |
| 11 | Neutropenia | 74 | 14.2 | 15.5 | signal |
| 12 | Hepatic Cytolysis | 6 | 12.7 | 12.8 | signal |
| 13 | Leukopenia | 23 | 12.0 | 12.3 | signal |
| 14 | Rash Maculo-papular | 10 | 11.7 | 11.9 | signal |
| 15 | Hepatotoxicity | 10 | 11.7 | 11.8 | signal |
| 16 | Haematotoxicity | 4 | 11.2 | 11.3 | signal |
| 17 | Tubulointerstitial Nephritis | 8 | 11.1 | 11.2 | signal |
| 18 | Thrombotic Microangiopathy | 3 | 8.0 | 8.1 | signal |
| 19 | Pneumocystis Jirovecii Pneumonia | 3 | 7.8 | 7.8 | signal |
| 20 | Nephropathy Toxic | 3 | 7.0 | 7.0 | signal |
| 21 | Product Storage Error | 17 | 5.1 | 5.2 | signal |